Abbott Labs’ surprise guidance bump is a major positive for its shareholders


An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Articles You May Like

Competition in the housing market is cooling off. Here’s why
Luxury homes on these beaches are losing value fast, as effects of climate change hit hard
Here’s the Fed’s new rate forecast that’s moving the markets
Robotics startup cofounded by Synapse CEO is raising funds with exaggerated claims about GM ties
Stellantis plans to grow Jeep sales 50% by 2027